Nimotuzumab is a monoclonal antibody and an endothelial growth factor receptor (EGRF) antagonist. It also stimulates the immune system against the cancer cells. It is a targeted therapy used for the treatment of glioma (cancer in the brain and spinal cord), cancer of the head and neck, and nasopharyngeal cancer.
Member Since 5 Years
Nature of Business Exporter
GST No. 34AAGCV3681B1ZH
For Buyer 
For Seller 
Help 
Saram, Pondicherry